Intellectual Property

PathMaker Neurosystems has exclusive worldwide rights to a fundamental portfolio of IP covering multi-site neuromodulation.  We pioneered the field of multi-site neuromodulation, and our foundational IP reflects this innovation.  Our DoubleStim® technology which underlies our MyoRegulator® device that is currently being used in ALS clinical trials is covered by over 40 issued patents in US, Europe and other territories. PathMaker holds trademark rights in its own corporate trademarks.